Clinical Trial Update: Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examined whether preloading magnesium can reduce cisplatin-induced nephrotoxicity in acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• CISPLATIN (cisplatin)
• Magnesium (magnesium)

Snippet

Sponsor: Mahidol University | Conditions: Acute Kidney Injury | Phase 4 | Status: COMPLETED